CAMBRIDGE, ON, Aug. 2, 2024
/PRNewswire/ - Advanced Electrophoresis Solutions Ltd. (AES), a
leading innovator in the field of capillary electrophoresis
technologies, is excited to announce the addition of three
distinguished executives to its leadership team, reinforcing its
commitment to innovation and market leadership in the
biopharmaceutical industry.
Mark Lies, PhD, Chief
Technology Officer (CTO)
Dr. Mark Lies, joins AES as the
new Chief Technology Officer. Dr. Lies brings significant
experience in product and market management, product ideation, and
strategy development from his previous roles at Beckman Coulter and
SCIEX. He has been instrumental in the commercialization of
capillary electrophoresis platforms which are widely used in the
analytical characterization of many biopharmaceutical
medicines.
Dr. Lies brings a wealth of expertise and a proven track record
in understanding industry needs and commercializing innovative
solutions. His deep knowledge of the business will greatly benefit
AES as the company continues to be at the forefront of innovation
in imaging capillary isoelectric focusing (iCIEF) and analytical
characterization markets. His leadership will further enhance AES's
commitment to advancing technology and meeting the evolving needs
of our clients.
"I am very excited to be taking on this role at AES," stated Dr.
Lies. "Through a clear understanding of customer problems,
innovative solutioning, and nimble execution in all areas, we seek
to grow our position in the iCIEF and analytical characterization
markets."
Matthew Courtney, PhD, Chief
Sales Officer (CSO)
Dr. Matthew Courtney serves as
the Chief Sales Officer at AES, where he leads efforts to
facilitate the adoption of new imaged capillary isoelectric
focusing (icIEF) tools for enhanced biotherapeutic development.
Holding a Ph.D. in Mechanical Engineering and a B.A.Sc. in
Nanotechnology Engineering from the University
of Waterloo, Dr. Courtney's specialization in capillary
electrophoresis technologies has positioned him as a key
contributor to advancing AES's offerings in the biopharmaceutical
industry.
Mike Li, CPA, Chief Finance
Officer (CFO)
Mike Li joins AES as Chief
Finance Officer. A graduate of McGill
University, Mike has been helping business owners since 2005
by focusing on key areas including day-to-day operations, tax
savings, succession/retirement planning, and financing. After
receiving his CPA designation, Mike completed the CICA In-Depth Tax
course in 2012. Outside of office hours, Mike enjoys spending time
with his young family and sharing his knowledge with his
community.
About Advanced Electrophoresis Solutions Ltd. (AES):
Advanced Electrophoresis Solutions Ltd (AES) is a pioneering
company in the field of capillary electrophoresis technologies,
dedicated to providing innovative solutions for the
biopharmaceutical industry. With a focus on imaging capillary
isoelectric focusing (iCIEF) and other analytical characterization
techniques, AES continues to drive advancements that enable the
development and analysis of biotherapeutics worldwide.
Link: https://aeslifesciences.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/advanced-electrophoresis-solutions-ltd-aes-announces-strategic-executive-appointments-to-drive-innovation-and-growth-302213509.html
SOURCE Advanced Electrophoresis Solutions